PAPERBIRCH STRATEGIES ON BEHALF OF AP3 BIOMEDICAL

Lobbying client · South Carolina · filed 2025 to 2026

Consulting / Company that specializes in advanced prostate cancer diagnostics.

$140,000 Reported spend

5 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 5 filings. Everything on this page is grouped by the client's LDA id (68867), not by name.

Firms hired 1

W STRATEGIES, LLC $140,000 5 filings

Reported by year 2 years

2026 $80,000 2 filings
2025 $60,000 3 filings

Issues lobbied 1

Health Issues 5

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 4
SENATE 1

Recent filings 5 total

Q2

W STRATEGIES, LLC

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $40,000 income · posted Jul 20, 2026

View → Q1

W STRATEGIES, LLC

1st Quarter (Jan 1 - Mar 31) 2026 · House · $40,000 income · posted Apr 18, 2026

View → Q4

W STRATEGIES, LLC

4th Quarter (Oct 1 - Dec 31) 2025 · House · $40,000 income · posted Jan 20, 2026

View → Q3

W STRATEGIES, LLC

3rd Quarter (July 1 - Sep 30) 2025 · House · $20,000 income · posted Oct 20, 2025

View → RR

W STRATEGIES, LLC

3rd Quarter (July 1 - Sep 30) 2025 · posted Sep 25, 2025

View →

Affiliated organisations 1

AP3 BIOMEDICAL Sweden named on 1 filing

Section 6 of the LD-2: organisations that contribute to or take part in this client's lobbying.

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.